Gilbert & Cook’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.18M | Buy |
9,210
+126
| +1% | +$14.7K | 0.14% | 69 |
|
|
2026
Q1 | $1.09M | Sell |
9,084
-25
| -0.3% | -$2.89K | 0.14% | 67 |
|
|
2025
Q4 | $959K | Buy |
9,109
+407
| +5% | +$38.2K | 0.12% | 83 |
|
|
2025
Q3 | $730K | Buy |
8,702
+95
| +1% | +$7.83K | 0.09% | 103 |
|
|
2025
Q2 | $681K | Buy |
8,607
+263
| +3% | +$20.9K | 0.09% | 107 |
|
|
2025
Q1 | $749K | Sell |
8,344
-1,219
| -13% | -$114K | 0.11% | 91 |
|
|
2024
Q4 | $951K | Sell |
9,563
-155
| -2% | -$16K | 0.13% | 73 |
|
|
2024
Q3 | $1.1M | Sell |
9,718
-54
| -0.6% | -$6.42K | 0.15% | 64 |
|
|
2024
Q2 | $1.21M | Sell |
9,772
-751
| -7% | -$96.7K | 0.18% | 50 |
|
|
2024
Q1 | $1.39M | Buy |
10,523
+107
| +1% | +$13.2K | 0.19% | 49 |
|
|
2023
Q4 | $1.14M | Sell |
10,416
-1,774
| -15% | -$184K | 0.16% | 60 |
|
|
2023
Q3 | $1.25M | Sell |
12,190
-1,973
| -14% | -$213K | 0.2% | 41 |
|
|
2023
Q2 | $1.63M | Buy |
14,163
+600
| +4% | +$68.1K | 0.26% | 29 |
|
|
2023
Q1 | $1.44M | Buy |
13,563
+119
| +0.9% | +$12.8K | 0.25% | 28 |
|
|
2022
Q4 | $1.49M | Sell |
13,444
-235
| -2% | -$24K | 0.27% | 29 |
|
|
2022
Q3 | $1.36M | Buy |
13,679
+307
| +2% | +$27.4K | 0.3% | 32 |
|
|
2022
Q2 | $1.22M | Buy |
13,372
+640
| +5% | +$56.7K | 0.22% | 36 |
|
|
2022
Q1 | $1.04M | Buy |
12,732
+546
| +4% | +$43K | 0.17% | 44 |
|
|
2021
Q4 | $934K | Buy |
12,186
+4,269
| +54% | +$340K | 0.15% | 54 |
|
|
2021
Q3 | $595K | Buy |
7,917
+679
| +9% | +$51.6K | 0.11% | 81 |
|
|
2021
Q2 | $563K | Sell |
7,238
-171
| -2% | -$12.7K | 0.1% | 84 |
|
|
2021
Q1 | $545K | Buy |
7,409
+550
| +8% | +$40.6K | 0.11% | 79 |
|
|
2020
Q4 | $537K | Buy |
6,859
+934
| +16% | +$71.4K | 0.12% | 67 |
|
|
2020
Q3 | $469K | Sell |
5,925
-5,688
| -49% | -$446K | 0.11% | 66 |
|
|
2020
Q2 | $857K | Buy |
11,613
+889
| +8% | +$66.9K | 0.21% | 39 |
|
|
2020
Q1 | $787K | Buy |
10,724
+717
| +7% | +$56.4K | 0.23% | 39 |
|
|
2019
Q4 | $868K | Buy |
10,007
+959
| +11% | +$78.8K | 0.21% | 43 |
|
|
2019
Q3 | $727K | Buy |
9,048
+3,013
| +50% | +$241K | 0.2% | 45 |
|
|
2019
Q2 | $483K | Sell |
6,035
-653
| -10% | -$50K | 0.14% | 57 |
|
|
2019
Q1 | $530K | Sell |
6,688
-171
| -2% | -$12.8K | 0.16% | 48 |
|
|
2018
Q4 | $500K | Buy |
6,859
+944
| +16% | +$66.6K | 0.18% | 49 |
|
|
2018
Q3 | $400K | Buy |
5,915
+20
| +0.3% | +$1.27K | 0.12% | 59 |
|
|
2018
Q2 | $341K | Buy |
5,895
+458
| +8% | +$25.8K | 0.12% | 61 |
|
|
2018
Q1 | $283K | Sell |
5,437
-157
| -3% | -$8.48K | 0.1% | 65 |
|
|
2017
Q4 | $300K | Sell |
5,594
-31
| -0.6% | -$1.72K | 0.1% | 59 |
|
|
2017
Q3 | $344K | Sell |
5,625
-5,081
| -47% | -$308K | 0.13% | 48 |
|
|
2017
Q2 | $655K | Buy |
10,706
+4,972
| +87% | +$303K | 0.23% | 43 |
|
|
2017
Q1 | $348K | Buy |
5,734
+428
| +8% | +$26K | 0.14% | 49 |
|
|
2016
Q4 | $298K | Buy |
+5,306
| New | +$311K | 0.13% | 56 |
|
Other funds holding MRK
ECSS
Gilbert & Cook's MRK Position: Q2 2026 in Review
Gilbert & Cook increased its Merck (MRK) stake by 1.4% in Q2 2026, buying an estimated $14.7K and bringing the position to 9,210 shares worth $1.18M. The position accounts for 0.14% of the portfolio, ranked #69.
Gilbert & Cook first reported a position in MRK in Q4 2016 and has held it in 39 quarters since. The position peaked at $1.63M in Q2 2023. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Gilbert & Cook held 9,210 shares of Merck worth $1.18M as of Q2 2026.
- Gilbert & Cook bought 126 Merck shares in Q2 2026, an estimated $14.7K.
- Merck made up 0.14% of Gilbert & Cook's portfolio in Q2 2026, its #69 holding.
- Gilbert & Cook first reported a position in Merck in Q4 2016 and has held it in 39 quarters since.
- Gilbert & Cook's Merck position peaked at $1.63M in Q2 2023.
- 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Gilbert & Cook's 13F filing for Q2 2026, filed 28 Jul 2026.